Quantitative Human PSCA (Glycosylated) Sandwich ELISA Kit

The quantitative human PSCA (glycosylated) sandwich ELISA kit is designed to detect human prostate stem cell antigen (PSCA) levels. PSCA is a glycosylphosphatidylinositol-anchored cell surface protein highly expressed in prostate tissue and overexpressed in several cancers, including prostate, bladder, and pancreatic cancers. It is involved in cell proliferation, adhesion, and survival, making it a potential biomarker and therapeutic target in oncology. The kit is suitable for various biological samples such as tissue homogenates, cell lysates. Its sensitivity is 0.091 ng/mL, which can accurately detect low concentrations of PSCA in the sample.

PSCA

Pre-coated ELISA plate; Lyophilized standard; Biotin-labeled antibody; HRP-avidin; Various diluents; Wash buffer; TMB chromogenic substrate; Stop solution

Tissue homogenates, cell lysates

100 μL

0.091 ng/mL

Quantitative sandwich ELISA

1 ng/mL-10 ng/mL

1 h-5 h

450 nm

Store at 2-8°C for long term storage.

Human

Prostate stem cell antigen

PSCA; Prostate stem cell antigen

31

The quantitative human PSCA (glycosylated) sandwich ELISA kit is used for the precise measurement of glycosylated PSCA levels in human biological samples. This highly sensitive and specific assay enables researchers to assess PSCA expression quantitatively, facilitating studies on tumor progression, metastasis, and patient response to therapies.

Intra-Assay: n=20, CV <8%;
Inter-Assay: n=20, CV <10%;

Serum sample: n=5, 80-95%;
Plasma sample: n=4, 80-100%;

The standard curve is for reference only, and a new standard curve should be generated for each set of samples tested.